Related Experiment Videos
Medication-induced upper gastrointestinal tract injury
Z Chen1, J R Scudiere, E Montgomery
1Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Diagnosing medication-induced upper gastrointestinal injuries is challenging due to non-specific histological changes. This review provides pathologists with a guide to recognize these injuries using histological patterns, medication fragments, and clinical data.
Area of Science:
- Gastroenterology
- Pathology
- Toxicology
Background:
- Medication-induced upper gastrointestinal (GI) injuries are common but underreported in pathology.
- Histological changes are often non-specific, complicating diagnosis.
- Diagnosis relies on histological patterns, medication fragments, and clinical data.
Purpose of the Study:
- To provide a practical guide for pathologists.
- To aid in the recognition and diagnosis of medication-induced upper GI injuries.
- To discuss key features of common medication-induced upper GI injuries.
Main Methods:
- Review of histological patterns associated with medication toxicity.
- Identification of morphological clues like pill fragments and crystal deposition.
- Emphasis on the importance of clinical correlation, including medication history and endoscopic findings.
Main Results:
- Specific histological patterns can suggest medication effects or toxicity.
- Morphological evidence such as pill fragments can be diagnostic.
- Clinical data is essential for differential diagnosis, especially when histological changes are non-specific.
Conclusions:
- Accurate diagnosis of medication-induced upper GI injuries requires a multi-faceted approach.
- Integrating histological findings with clinical information is crucial.
- Pathologists can improve diagnostic accuracy with a systematic approach and awareness of key features.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...